Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 11/2010

Content (14 Articles)

Original Article

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

Florian Cabillic, Olivier Toutirais, Vincent Lavoué, Cécile Thomas de La Pintière, Pascale Daniel, Nathalie Rioux-Leclerc, Bruno Turlin, Hannu Mönkkönen, Jukka Mönkkönen, Karim Boudjema, Véronique Catros, Françoise Bouet-Toussaint

Original Article

Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells

Juan Dubrot, Aitziber Portero, Gorka Orive, Rosa María Hernández, Asis Palazón, Ana Rouzaut, Jose L. Perez-Gracia, Sandra Hervás-Stubbs, Jose Luis Pedraz, Ignacio Melero

Original Article

Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant

Jessica C. Shand, Johan Jansson, Yu-Chiao Hsu, Andrew Campbell, Craig A. Mullen

Original Article

Leukemic cell products down-regulate human dendritic cell differentiation

Juliana Maria Motta, Clarissa Rodrigues Nascimento, Vivian Mary Rumjanek

Original Article

Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion

Alexander J. Muller, James B. DuHadaway, Mee Young Chang, Arivudinambi Ramalingam, Erika Sutanto-Ward, Janette Boulden, Alejandro P. Soler, Laura Mandik-Nayak, Susan K. Gilmour, George C. Prendergast

Open Access Original Article

A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth

Merete Thune Wiiger, Hege B. Gehrken, Øystein Fodstad, Gunhild M. Mælandsmo, Yvonne Andersson

Original Article

Efficacy of catumaxomab in tumor spheroid killing is mediated by its trifunctional mode of action

Franziska Hirschhaeuser, Stefan Walenta, Wolfgang Mueller-Klieser

Original Article

Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles

Sharmila Pejawar-Gaddy, Yogendra Rajawat, Zoe Hilioti, Jia Xue, Daniel F. Gaddy, Olivera J. Finn, Raphael P. Viscidi, Ioannis Bossis

Original Article

Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load

Wei Dong, Jiajun Du, Hongchang Shen, Dongwei Gao, Zhenxiang Li, Guanghui Wang, Xueru Mu, Qi Liu

Original Article

Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer

Jingting Jiang, Yibei Zhu, Changping Wu, Yueping Shen, Wenxiang Wei, Lujun Chen, Xiao Zheng, Jing Sun, Binfeng Lu, Xueguang Zhang

Original Article

Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice

Tae-Young Lee, Yang-Hyun Kim, Kyung-Soon Lee, Jeong-Ki Kim, Il-Han Lee, Jai-Myung Yang, Moon-Hee Sung, Jong-Sup Park, Haryoung Poo

Short communication

Allogeneic natural killer cells for refractory lymphoma

Veronika Bachanova, Linda J. Burns, David H. McKenna, Julie Curtsinger, Angela Panoskaltsis-Mortari, Bruce R. Lindgren, Sarah Cooley, Daniel Weisdorf, Jeffrey S. Miller

Meeting Report

Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany

Evelyn Ullrich, Jacobus Bosch, Michael Aigner, Simon Völkl, Diana Dudziak, Bernd Spriewald, Gerold Schuler, Reinhard Andreesen, Andreas Mackensen

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine